Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer
出版年份 2023 全文链接
标题
Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer
作者
关键词
-
出版物
Molecular Diagnosis & Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-01
DOI
10.1007/s40291-023-00680-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 12P CRISPR/Cas9-induced knock-out of DGKαζ in TAG-72 CAR-T cells improves function and persistence in ovarian cancer
- (2023) V. Evtimov et al. ESMO Open
- CRISPR prime editing for unconstrained correction of oncogenic KRAS variants
- (2023) Gayoung Jang et al. Communications Biology
- TRIB3 reduces CD8 + T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer
- (2022) Shuang Shang et al. Science Translational Medicine
- Hallmarks of Cancer: New Dimensions
- (2022) Douglas Hanahan Cancer Discovery
- Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
- (2022) Alain E. Andrea et al. Frontiers in Immunology
- Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update
- (2022) Aristeidis E. Boukouris et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis
- (2022) Xiao Zhang et al. World Journal of Surgical Oncology
- Emerging Strategies in TCR-Engineered T Cells
- (2022) Fang Wei et al. Frontiers in Immunology
- Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
- (2022) Christopher Aled Chamberlain et al. Molecular Therapy-Oncolytics
- Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity
- (2022) Pierre-Louis Bernard et al. Journal for ImmunoTherapy of Cancer
- Decreasing HPK1 expression in CD19 CAR-T cells: A novel strategy to overcome challenges of cell therapy for adult (r/r) B-ALL.
- (2022) Na Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of TAMs in Tumor Microenvironment and New Research Progress
- (2022) Yawei Feng et al. Stem Cells International
- CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling
- (2022) Samantha M Fix et al. Journal for ImmunoTherapy of Cancer
- Lymphopenic condition enhanced the antitumor immunity of PD-1-knockout T cells mediated by CRISPR/Cas9 system in malignant melanoma
- (2022) Zike Yang et al. IMMUNOLOGY LETTERS
- CD166-specific CAR-T cells potently target colorectal cancer cells
- (2022) Shuai He et al. Translational Oncology
- Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels
- (2022) Jiang Lv et al. Molecular Therapy-Oncolytics
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy
- (2021) Per Anderson et al. Cellular & Molecular Immunology
- Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Treg Phenotype
- (2021) Christopher Kressler et al. Frontiers in Immunology
- Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function
- (2021) Jitendra Kumar et al. Journal for ImmunoTherapy of Cancer
- Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment
- (2021) Zhiling Yan et al. Frontiers in Immunology
- Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma
- (2021) Ke Wu et al. Aging-US
- STAT6 Is Critical for the Induction of Regulatory T Cells In Vivo Controlling the Initial Steps of Colitis-Associated Cancer
- (2021) Yael Delgado-Ramirez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Next generation of immune checkpoint inhibitors and beyond
- (2021) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
- (2021) Nicoletta Caronni et al. Nature Communications
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Genome Editing in Bacteria: CRISPR-Cas and Beyond
- (2021) Ruben D. Arroyo-Olarte et al. Microorganisms
- Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
- (2021) Zhenguang Wang et al. Cellular & Molecular Immunology
- CAR T cells: Building on the CD19 paradigm
- (2021) Anat Globerson Levin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research
- (2021) Fahreddin Palaz et al. ACS Synthetic Biology
- Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses
- (2021) Yanping Yang et al. Cancer Immunology Research
- CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells
- (2021) Camilla Wilk et al. CELLULAR IMMUNOLOGY
- Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
- (2021) Cristina Aparicio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineering NK-92 Cell by Upregulating CXCR2 and IL-2 Via CRISPR-Cas9 Improves Its Antitumor Effects as Cellular Immunotherapy for Human Colon Cancer
- (2021) Lanlan Gao et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
- (2021) William W. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting role
- (2021) Junhui Yu et al. Cell Death Discovery
- Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
- (2020) Ramesh Pothuraju et al. Molecular Cancer
- Cas9 Mediated Correction of β-catenin Mutation and Restoring the Expression of Protein Phosphorylation in Colon Cancer HCT-116 Cells Decrease Cell Proliferation in vitro and Hamper Tumor Growth in Mice in vivo
- (2020) Yanlan Li et al. OncoTargets and Therapy
- Immunotherapy, Inflammation and Colorectal Cancer
- (2020) Charles Robert Lichtenstern et al. Cells
- Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors.
- (2020) Zhenguang Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
- (2020) Nathan Karin Frontiers in Immunology
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials
- (2020) Khalil Khalaf et al. Genes
- Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
- (2020) Zachary Jackson et al. Frontiers in Immunology
- Immune escape: A critical hallmark in solid tumors
- (2020) Keywan Mortezaee LIFE SCIENCES
- The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
- (2020) Shogo Kumagai et al. NATURE IMMUNOLOGY
- PD-1+ Treg cells: a foe in cancer immunotherapy?
- (2020) Halil-Ibrahim Aksoylar et al. NATURE IMMUNOLOGY
- Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity
- (2020) Wouter Laurentius Smit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells
- (2020) Tianzhen He et al. Science Advances
- CAR-T cells: Early successes in blood cancer and challenges in solid tumors
- (2020) Hassan Dana et al. Acta Pharmaceutica Sinica B
- Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them
- (2019) M. A. F. Yahaya et al. Journal of Immunology Research
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- One-step generation of modular CAR-T cells with AAV–Cpf1
- (2019) Xiaoyun Dai et al. NATURE METHODS
- Preclinical Evaluation of Chimeric Antigen Receptor–Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer
- (2019) Bing-Lan Zhang et al. HUMAN GENE THERAPY
- Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis
- (2019) Giuseppe Troiano et al. ORAL ONCOLOGY
- CRISPR-Cas9–mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes
- (2019) Haruna Takeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12
- (2019) Xiaowei Chi et al. Cancer Medicine
- Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes
- (2019) Guifang Guo et al. Journal for ImmunoTherapy of Cancer
- Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression
- (2019) Barry A. Kriegsman et al. JOURNAL OF IMMUNOLOGY
- Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
- (2019) Youn Young Park et al. MEDICINE
- Cas9-edited immune checkpoint blockade PD-1 DNA polyaptamer hydrogel for cancer immunotherapy
- (2019) Jaiwoo Lee et al. BIOMATERIALS
- Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
- (2019) Ibrahim Halil Sahin et al. BRITISH JOURNAL OF CANCER
- Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
- (2019) Beau R. Webber et al. Nature Communications
- MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
- (2019) Zi Mei et al. Cancer Medicine
- c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival
- (2018) Su Jin Lee et al. Clinical Colorectal Cancer
- Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research
- (2018) Andrea Necchi et al. Clinical Genitourinary Cancer
- NKG2D and its ligands in cancer
- (2018) Payal Dhar et al. CURRENT OPINION IN IMMUNOLOGY
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy
- (2018) Chi Zhang et al. Scientific Reports
- Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
- (2018) Michael S. Magee et al. Cancer Immunology Research
- MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
- (2018) Irene Romero et al. Frontiers in Immunology
- Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
- (2018) Soumaya Kouidhi et al. Frontiers in Immunology
- CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
- (2018) Yao Wang et al. OncoImmunology
- CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
- (2018) Wanghong Hu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes
- (2017) Long Shi et al. GENE
- Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer
- (2017) Rehan Ahmad et al. Molecular Cancer
- In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis
- (2017) Jatin Roper et al. NATURE BIOTECHNOLOGY
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes
- (2017) Zhilong Zhao et al. Oncotarget
- PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
- (2017) Xinru Wei et al. OncoImmunology
- Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
- (2017) Kristen M. Hege et al. Journal for ImmunoTherapy of Cancer
- PD-1 blockade modulates chimeric antigen receptor (CAR)–modified T cells: refueling the CAR
- (2016) Elise A. Chong et al. BLOOD
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
- (2016) Christophe Massard et al. JOURNAL OF CLINICAL ONCOLOGY
- The Prognostic Significance of FoxP3+ T Cells and CD8+ T Cells in Colorectal Carcinomas
- (2016) Asuman Argon et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
- (2016) Takuro Saito et al. NATURE MEDICINE
- Repurposing the CRISPR-Cas9 system for targeted DNA methylation
- (2016) Aleksandar Vojta et al. NUCLEIC ACIDS RESEARCH
- CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
- (2016) Shu Su et al. OncoImmunology
- Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
- (2015) X. Liu et al. CANCER RESEARCH
- CD8+ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity
- (2015) G Elizabeth Pluhar et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Cish actively silences TCR signaling in CD8 + T cells to maintain tumor tolerance
- (2015) Douglas C. Palmer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sequential cancer mutations in cultured human intestinal stem cells
- (2015) Jarno Drost et al. NATURE
- Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
- (2015) Aaron Prodeus et al. Molecular Therapy-Nucleic Acids
- Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
- (2013) D. McDermott et al. ANNALS OF ONCOLOGY
- Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice
- (2011) Jinlin Liu et al. PLoS One
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
- (2009) Bernhard Mlecnik et al. GASTROENTEROLOGY
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
- (2008) Paul Salama et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started